ResMed
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	6/30/2022	6/30/2023	6/30/2024	6/30/2026	6/30/2027	6/30/2028
Revenue % change YoY	$3.57B N/A	$4.22B 18.02%	$4.68B 10.94%	Avg: $5.37B Low: $5.37B High: $5.37B avg. 14.82%	Avg: $5.69B Low: $5.69B High: $5.69B avg. 5.88%	Avg: $6.14B Low: $6.14B High: $6.14B avg. 7.96%
Net Income % change YoY	$779.43M N/A	$897.55M 15.15%	$1.02B 13.74%	Avg: $1.42B Low: $1.42B High: $1.42B avg. 39.37%	Avg: $1.50B Low: $1.50B High: $1.50B avg. 5.63%	Avg: $1.54B Low: $1.54B High: $1.54B avg. 3.00%
EBITDA % change YoY	$1.19B N/A	$1.35B 13.79%	$1.53B 12.86%	Avg: $1.78B Low: $1.78B High: $1.78B avg. 16.27%	Avg: $1.88B Low: $1.88B High: $1.88B avg. 5.88%	Avg: $2.03B Low: $2.03B High: $2.03B avg. 7.96%
EPS % change YoY	$5.34 N/A	$6.12 14.60%	$6.94 13.39%	Avg: $0.96 Low: $0.96 High: $0.96 avg. -86.09%	Avg: $1.02 Low: $1.02 High: $1.02 avg. 5.63%	Avg: $1.05 Low: $1.05 High: $1.05 avg. 3.00%
Operating Expenses % change YoY	$1.02B N/A	$1.20B 17.54%	$1.33B 10.94%	Avg: $1.18B Low: $1.18B High: $1.18B avg. -11.40%	Avg: $1.25B Low: $1.25B High: $1.25B avg. 5.88%	Avg: $1.35B Low: $1.35B High: $1.35B avg. 7.96%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 16.00% in 2026-2028.

We have gathered data from N/A analysts. Their low estimate is 1.42B, average is 1.42B and high is 1.42B.

Wall Street analysts forecast annual average revenue growth of 9.55% in 2026-2028.

We have gathered data from N/A analysts. Their low revenue estimate is $5.37B, average is $5.37B and high is $5.37B.

Wall Street analysts forecast annual average earnings growth of -25.81% in 2026-2028.

We have gathered data from N/A analysts. Their low earnings per share estimate is $0.96, average is $0.96 and high is $0.96.